BrightSpring Health Services, Inc. Common Stock
Here’s whether BrightSpring Health Services, Inc. Common Stock (BTSG) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.14% over 10 days); strong 1-year return of +193.7%; 3-month momentum positive (+29.9%); rising volume confirms the move (1.26x 30d avg). Concerns: RSI 75 — overbought, elevated pullback risk. Currently 3.8% off its 52-week high. Score: +6/7.
BTSG is in a confirmed uptrend, trading above both its 50-day ($43.69) and 200-day ($34.41) moving averages. With an RSI of 75.3, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +193.7% compares to +27.9% for SPY (beat the market by 165.9%).